Advancing Heart Failure Care: The Expanding Role of MRAs in HFmrEF and HFpEF

Gain strategies for meeting the unmet therapeutic need for patients with heart failure with mid-range or preserved ejection fraction, including current data on mineralocorticoid receptor agonists and how to implement these therapies in patient-centered treatment plans, through expert-written ClinicalThought commentaries, a text module with accompanying slides, and a podcast.

Share

Program Content

Activities

Expanding Role of MRAs in Heart Failure
Expanding Role of MRAs in Heart Failure: Bridging the Gap Between Evidence and Clinical Practice
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 22, 2025

Expires: April 21, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options

Supporters

This activity is supported by an independent medical education grant from Bayer HealthCare Pharmaceuticals, Inc.

Bayer HealthCare Pharmaceuticals Inc.